Retinitis Pigmentosa News and Research

RSS
Retinitis pigmentosa (RP) is the name given to a group of inherited eye diseases that affect the retina (the light-sensitive part of the eye). RP causes the breakdown of photoreceptor cells (cells in the retina that detect light). Photoreceptor cells capture and process light helping us to see. As these cells breakdown and die, patients experience progressive vision loss. The most common feature of all forms of RP is a gradual breakdown of rods (retinal cells that detect dim light) and cones (retinal cells that detect light and color). Most forms of RP first cause the breakdown of rod cells. These forms of RP, sometimes called rod-cone dystrophy, usually begin with night blindness. Night blindness is somewhat like the experience normally sighted individuals encounter when entering a dark movie theatre on a bright, sunny day. However, patients with RP cannot adjust well to dark and dimly lit environments.
Light can be used to control cellular functions, optogenetics study shows

Light can be used to control cellular functions, optogenetics study shows

CIRM funds clinical study to test safety, efficacy of new retinitis pigmentosa treatment

CIRM funds clinical study to test safety, efficacy of new retinitis pigmentosa treatment

Study findings could lead to novel therapies for preventing vision loss from degenerative retinal diseases

Study findings could lead to novel therapies for preventing vision loss from degenerative retinal diseases

Novel nanoengineered retinal prosthesis may help restore eyesight

Novel nanoengineered retinal prosthesis may help restore eyesight

New research identifies signal that appears to trigger retinal regeneration in zebrafish

New research identifies signal that appears to trigger retinal regeneration in zebrafish

UAB researchers show how GARP2 protein accelerates retinal degeneration in mice

UAB researchers show how GARP2 protein accelerates retinal degeneration in mice

NEI highlights new technologies and tools to help people living with low vision or blindness

NEI highlights new technologies and tools to help people living with low vision or blindness

Scientists develop unique method to fix genes in living organisms

Scientists develop unique method to fix genes in living organisms

New glasses may help expand sight of person with limited peripheral vision

New glasses may help expand sight of person with limited peripheral vision

Retinitis pigmentosa can be slowed by reprogramming metabolism of photoreceptors, study shows

Retinitis pigmentosa can be slowed by reprogramming metabolism of photoreceptors, study shows

Researchers start enrolling patients for Phase II gene therapy trial for choroideremia

Researchers start enrolling patients for Phase II gene therapy trial for choroideremia

Second Sight successfully implants wireless multichannel neurostimulation system in human subject

Second Sight successfully implants wireless multichannel neurostimulation system in human subject

Encapsulated cell therapy could be new way to fight glaucoma

Encapsulated cell therapy could be new way to fight glaucoma

Research findings offer promising treatment target for blinding diseases

Research findings offer promising treatment target for blinding diseases

IU receives $1.9 million grant to investigate effects of congenital birth defects and age on the eye

IU receives $1.9 million grant to investigate effects of congenital birth defects and age on the eye

NanoScope awarded AGI Grant to re-sensitize photo-degenerated retinal areas with MCO

NanoScope awarded AGI Grant to re-sensitize photo-degenerated retinal areas with MCO

Research opens way towards making promising advances in retinal prostheses

Research opens way towards making promising advances in retinal prostheses

Interim results from clinical trial demonstrate safety of cell-based therapy for retinitis pigmentosa

Interim results from clinical trial demonstrate safety of cell-based therapy for retinitis pigmentosa

Shire’s Xiidra receives FDA approval for treating dry eye disease in adult patients

Shire’s Xiidra receives FDA approval for treating dry eye disease in adult patients

Pain reliever appears to help preserve vision in animal model of retinal degeneration

Pain reliever appears to help preserve vision in animal model of retinal degeneration

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.